Fri, Jan 30, 2015, 4:11 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

AMAG Pharmaceuticals, Inc. Message Board

  • jrus2010 jrus2010 Apr 29, 2011 3:33 PM Flag

    Venofer in trouble

    Pharmacies and renal units being told by Venofer reps that only limited supplies will be available from existing Luipold stock and that they can't guarantee short-term availability once those run out.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • jrus...Im out of the field now and retired...can AMAG fill the supply weakness iyo?

      I can not see amag lowering p when supply is short so I rather doubt any rebates offered going forward... in fact I would take em off the table, period.

      This means Q-2 could be a blow out quarter!

      I would not be selling any amag shares this summer! That would be ludicrous now!Not even trading shares at this point!

      Frank

      • 1 Reply to frankfrazzano
      • Don't know if they can fill the demand with their product. Don't think AMAG's execution has been great. This is probably the biggest opportunity since their drug got approved.

        Also heard that Sanofi's Ferrlicet product is experiencing shortages - lets hope AMAG can rise to the occasion. Do think they should have a record Q2-Q3

 
AMAG
44.15-0.53(-1.19%)3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.